Zobrazeno 1 - 10
of 16
pro vyhledávání: '"K S, Pentlow"'
Autor:
P. Backhaus, K. S. Pentlow, A. L. Hoe, A. Mauguen, J. A. Fagin, N. K. Pillarsetty, S. Larson, H. Schoder, J. O'Donoghue, W. Weber, R. K. Grewal
Publikováno v:
61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
K S Pentlow, L N Rothenberg
Publikováno v:
RadioGraphics. 12:1225-1243
The energy deposited in the patient by the rotating x-ray beam in computed tomography produces more uniform absorbed dose values within the section of imaged tissue than those produced in conventional radiologic procedures. The dose values within a s
Autor:
A, Lövqvist, J L, Humm, A, Sheikh, R D, Finn, J, Koziorowski, S, Ruan, K S, Pentlow, A, Jungbluth, S, Welt, F T, Lee, M W, Brechbiel, S M, Larson
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(8)
Absorbed doses in (90)Y radioimmunotherapy are usually estimated by extrapolating from (111)In imaging data. PET using (86)Y (beta(+) 33%; half-life, 14.7 h) as a surrogate radiolabel could be a more accurate alternative. The aim of this study was to
Autor:
Ronglai Shen, D. G. Pfister, Alan Loh Ho, E. J. Sherman, P. B. Zanzonico, R. Leboeuf, R. A. Ghossein, S. Haque, José Carlos de Miguel Domínguez, J. C. Ricarte-Filho, S. Gavane, K. S. Pentlow, R. K. Grewal, Michele Marinò, J. A. Fagin, D. Deandreis, R. M. Tuttle, S. M. Larson
Publikováno v:
L'Endocrinologo. 14:95-95
Autor:
K S, Pentlow, M C, Graham, R M, Lambrecht, F, Daghighian, S L, Bacharach, B, Bendriem, R D, Finn, K, Jordan, H, Kalaigian, J S, Karp, W R, Robeson, S M, Larson
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(9)
PET is potentially very useful for the accurate in vivo quantitation of time-varying biological distributions of radiolabeled antibodies over several days. The short half-lives of most commonly used positron-emitting nuclides make them unsuitable for
Autor:
G, Sgouros, S, Chiu, K S, Pentlow, L J, Brewster, H, Kalaigian, B, Baldwin, F, Daghighian, M C, Graham, S M, Larson, R, Mohan
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 34(9)
Absorbed-dose calculations for radioimmunotherapy are generally based on tracer imaging studies of the labeled antibody. Such calculations yield estimates of the average dose to normal and target tissues assuming idealized geometries for both the rad
Autor:
S M, Larson, K S, Pentlow, N D, Volkow, A P, Wolf, R D, Finn, R M, Lambrecht, M C, Graham, G, Di Resta, B, Bendriem, F, Daghighian
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 33(11)
A patient with advanced neuroblastoma who had failed chemotherapy presented with a large abdominal mass and virtually total bone marrow replacement by tumor on repeated marrow biopsies. She was considered a candidate for a Phase I 131I-3F8 radioimmun
Publikováno v:
Medical physics. 18(3)
Positron emission tomography (PET) is potentially useful for the quantitative imaging of radiolabeled antibodies, leading in turn to improved dosimetry in radioimmunotherapy. Iodine-124 is a positron-emitting nuclide with appropriate chemical propert
Publikováno v:
Nuclear Medicine Communications. 22:939
Autor:
L. N. Rothenberg, C. K. Showalter, D. R. White, T. B. Shope, Robert D. Speller, T. J. Morgan, K. S. Pentlow
Publikováno v:
The British Journal of Radiology. 54:1053-1061
During the past three years, 23 computerized tomography (CT) machines from ten different manufacturers located in Europe and the USA have been evaluated. Using the same set of phantoms and measurement techniques, performance data have been derived in